Product Image

Brain

Host Defense MycoBotanicals
4.6
★ ★ ★ ★ ★
(3105 ratings)
Ginkgo
Hericium mushroom 300 mg
Bacopa 250 mg
Cordyceps 50 mg
Reishi mushroom 150 mg
Product Image
Score77
A coherent stimulant-free cognitive stack has a useful ginkgo amount, but unstandardized extracts make the rest of the formula less predictable.
How scoring works
Quantity:60 Capsule(s) • (30 servings)
Goals:
Productivity Boost
Cognitive Support
Brain Health
Mental Focus

Score 77

A coherent stimulant-free cognitive stack has a useful ginkgo amount, but unstandardized extracts make the rest of the formula less predictable.
How scoring works
$23.96($0.79 per serving)
Amazon
$ 23.96
Vitacost
$ 23.97
Walmart
$ 23.96
iHerb
$ 23.97
Pure Formulas
$ 23.96
Vitacost
$ 23.99
Report prices

Analysis

Ginkgo reaches 120 mg and provides the clearest dose-aligned cognitive ingredient. Bacopa, lion’s mane, and gotu kola broaden support across memory, circulation, and neural-health pathways.

Bacopa lacks bacoside standardization, and the mushrooms have no extraction or beta-glucan details. Cordyceps is present at only 50 mg, so it is unlikely to add much fatigue support.

The blend avoids caffeine and keeps all active amounts visible. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Who is it for
  • Adults seeking stimulant-free cognitive support
  • People wanting several botanical brain pathways in one formula
Best for
  • Memory and mental clarity routines
  • Stimulant-free productivity support

Pros

  • Useful ginkgo amount
  • Bacopa and lion’s mane broaden cognitive coverage
  • No caffeine source
  • All active amounts are disclosed

Cons

  • Ginkgo marker standardization is absent
  • Bacopa bacoside yield is unknown
  • Mushroom extraction details are missing
  • Cordyceps amount is low

Warnings

  • Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.
  • Bacopa can cause nausea, cramping, or loose stools in sensitive users.
  • Ginkgo may lower seizure threshold and is unsuitable for people with seizure disorders without clinical guidance.

Nutrient quality

81 Highest impact

A focused cognitive stack and useful ginkgo amount provide strong intended-use alignment without padding. Missing standardization and modest mushroom amounts keep potency less predictable.

.

Ingredient transparency

79 High impact

Every active amount is disclosed without a hidden blend, and several botanical identities are specific. Missing marker standards, mushroom quality details, directions, and excipients leave meaningful gaps.

.

Customer satisfaction

71 High impact

The aggregate rating is strong, but it provides no specific experience evidence. The large review count gives the broad signal a useful volume base, while no detailed feedback supports taste, tolerance, or recurring-problem assessment.

.

Value for money

76 High impact

Focused cognitive coverage and fair relative serving cost provide good value without padding. Missing potency standards keep the formula from competing with clinically defined extracts.

.
Report analysis

Goals

Productivity Boost
Impact
High effect
B Goal FitC- Strength of SupportB CoverageB+ Formula Quality
Cordyceps · 50 mgCordyceps · 50 mgCordyceps · 50 mg

Bacopa, ginkgo, lion’s mane, reishi, and cordyceps create a focused botanical and mushroom formula for memory, clarity, and fatigue resistance. Its ingredient choices span several productivity pathways without relying on stimulants.

Ginkgo reaches a useful amount, but bacopa is slightly low and mushroom amounts and standardization are weak. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Bacopa Supportive 12 studies
Cordyceps Not classified 1 study
Cordyceps Not classified 1 study
Cordyceps Not classified 1 study
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Hericium mushroom Disputed 2 studies
Cognitive Support
Impact
High effect
B Goal FitD+ Strength of SupportB- CoverageA- Formula Quality
Bacopa · 250 mgHericium mushroom · 300 mg

Ginkgo, bacopa, lion’s mane, and gotu kola directly address circulation, memory, and neuro-support pathways. The ingredient selection is strong, but lion’s mane is modest and no extract provides the marker standardization needed to confirm clinical potency.

The compact botanical stack is coherent and avoids unrelated fillers. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines, and the missing ginkgolic-acid purity assurance adds uncertainty.

Study evidence
Bacopa Supportive 30 studies
Ginkgo Supportive 87 studies
Brain Health
Impact
Moderate effect
B- Goal FitD Strength of SupportC+ CoverageB+ Formula Quality
Bacopa · 250 mg

Lion’s mane, bacopa, ginkgo, gotu kola, reishi, and cordyceps create a clearly targeted botanical brain-health blend. Ginkgo reaches a useful extract amount, while missing bacoside, beta-glucan, extraction, and other standardization details weaken confidence in the rest of the formula.

The combination covers memory, circulation, stress resilience, and possible neurotrophic support without unrelated vitamins or fillers. Ginkgo may increase bleeding risk for people using anticoagulant or antiplatelet medicines.

Study evidence
Bacopa Supportive 17 studies
Ginkgo Supportive 90 studies
Hericium mushroom Supportive 10 studies
Mental Focus
Impact
Moderate effect
C+ Goal FitD Strength of SupportC+ CoverageB Formula Quality

Ginkgo and bacopa give the botanical blend clear relevance to memory and attention, with lion’s mane and gotu kola adding broader cognitive support. Missing standardization and modest amounts make the likely effect less predictable.

The four-botanical approach is coherent and avoids unrelated padding, but it favors breadth over reliably strong dosing. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Bacopa Supportive 13 studies
Ginkgo Supportive 28 studies
Hericium mushroom No effect 1 study

Ingredients

IngredientAmount per serving
Lion's Mane
300 mg
Bacopa (Bacopa monnieri) whole plant extract
250 mg
Reishi
150 mg
Gotu Kola (Centella asiatica) aerial parts extract
130 mg
Ginkgo (Ginkgo biloba) leaf extract
120 mg
Cordyceps
50 mg
Gluten Free Adults 18–50 Organic
Report overview
Ginkgo · 120 mg OverallScore48
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value

The leaf extract amount reaches a clinically relevant range, although its marker standardization is not disclosed. The exact standalone amount is clear, but no qualifying ginkgolic acid purity assurance is supplied. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Hericium mushroom · 300 mg OverallScore36
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyB+ Value

The modest Lion's Mane amount and missing source details limit its fit for focused cognitive support. No extraction method or beta-glucan standardization is supplied, so bioavailability and active content remain uncertain. The exact amount is visible, but the lack of a no-grain or no-filler assurance leaves substrate purity unresolved.

Bacopa · 250 mg OverallScore24
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyF Value

No bacoside marker or standardization percentage is disclosed. No trademarked or clinically identified extract is named. The label identifies an appropriate whole-plant or aerial source. The 250 mg extract amount is moderately aligned with common extract dosing, while the serving cost is difficult to justify without a verified high-potency extract.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.
    Kongkeaw C; Dilokthornsakul P; Thanarangsarit P; Limpeanchob N; Norman Scholfield C · Journal of ethnopharmacology · 2014
    Meta-analysis518 participants9 studies pooledBrain Health Mental Focus Productivity Boost forBacopa
  2. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial.
    Mori K; Inatomi S; Ouchi K; Azumi Y; Tuchida T · Phytotherapy research : PTR · 2009
    Randomized trial30 participantsBrain Health Cognitive Support forHericium mushroom
  3. The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
    Feng X; Fan S; Wei F · Frontiers in pharmacology · 2026
    Meta-analysis1,861 participants25 studies pooledCognitive Support Brain Health forBacopa
  4. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  5. Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review.
    Crawford C; Boyd C; Deuster PA · Journal of alternative and complementary medicine (New York, N.Y.) · 2021
    Systematic review69 studies pooledBrain Health forBacopa
  6. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledCognitive Support forGinkgo
  7. The acute effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy normal subjects.
    Nathan PJ; Clarke J; Lloyd J; Hutchison CW; Downey L; Stough C · Human psychopharmacology · 2019
    Randomized trial38 participantsCognitive Support forBacopa
  8. Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
    Tiemtad P; Ingkaninan K; Temkitthawon P; Thimkorn P; Rattanachaisit N; Teaktong T; Dhippayom T · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
    Meta-analysis2,107 participants29 studies pooledCognitive Support Brain Health Mental Focus forBacopa
  9. Four Weeks of Hericium erinaceus Supplementation Does Not Impact Markers of Metabolic Flexibility or Cognition.
    Grozier CD; Alves VA; Killen LG; Simpson JD; O'Neal EK; Waldman HS · International journal of exercise science · 2025
    Non-randomized trial24 participantsBrain Health Cognitive Support Productivity Boost forHericium mushroom
  10. Brahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi (Bacopa monniera) in healthy adults.
    Sathyanarayanan V; Thomas T; Einöther SJ; Dobriyal R; Joshi MK; Krishnamachari S · Psychopharmacology · 2013
    Randomized trial72 participantsBrain Health forBacopa
  11. A review of the effects of mushrooms on mood and neurocognitive health across the lifespan.
    Cha S; Bell L; Shukitt-Hale B; Williams CM · Neuroscience and biobehavioral reviews · 2024
    Systematic review34 studies pooledBrain Health forHericium mushroom
  12. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  13. Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
    Verma J; Rathi R; Anamika; Rathi B; Pandey VB · Journal of Ayurveda and integrative medicine · 2025
    Randomized trial180 participantsBrain Health Cognitive Support forBacopa
  14. Plant-derived nootropics and human cognition: A systematic review.
    Lorca C; Mulet M; Arévalo-Caro C; Sanchez MÁ; Perez A; Perrino M; Bach-Faig A; Aguilar-Martínez A; Vilella E; Gallart-Palau X; Serra A · Critical reviews in food science and nutrition · 2023
    Systematic review256 studies pooledBrain Health forBacopa
  15. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  16. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  17. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  18. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  19. Acute Effects of Naturally Occurring Guayusa Tea and Nordic Lion's Mane Extracts on Cognitive Performance.
    La Monica MB; Raub B; Ziegenfuss EJ; Hartshorn S; Grdic J; Gustat A; Sandrock J; Ziegenfuss TN · Nutrients · 2023
    Randomized trialBrain Health Productivity Boost forHericium mushroom
  20. Improvement of cognitive functions by oral intake of Hericium erinaceus.
    Saitsu Y; Nishide A; Kikushima K; Shimizu K; Ohnuki K · Biomedical research (Tokyo, Japan) · 2020
    Randomized trialBrain Health forHericium mushroom
  21. Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study.
    Surendran G; Saye J; Binti Mohd Jalil S; Spreadborough J; Duong K; Shatwan IM; Lilley D; Heinrich M; Dodd GF; Surendran S · Frontiers in nutrition · 2025
    Randomized trial18 participantsBrain Health Mental Focus forHericium mushroom
  22. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials.
    Pase MP; Kean J; Sarris J; Neale C; Scholey AB; Stough C · Journal of alternative and complementary medicine (New York, N.Y.) · 2012
    Systematic review6 studies pooledCognitive Support Productivity Boost forBacopa
  23. A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations.
    Kean JD; Downey LA; Stough C · Complementary therapies in medicine · 2017
    Systematic review5 studies pooledCognitive Support forBacopa
  24. Efficacy of Standardized Extract of Bacopa monnieri (Bacognize®) on Cognitive Functions of Medical Students: A Six-Week, Randomized Placebo-Controlled Trial.
    Kumar N; Abichandani LG; Thawani V; Gharpure KJ; Naidu MU; Venkat Ramana G · Evidence-based complementary and alternative medicine : eCAM · 2024
    Randomized trial60 participantsCognitive Support forBacopa
  25. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  26. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  27. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  28. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  29. Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial.
    Delfan M; Kordestani-Moghaddam P; Gholami M; Kazemi K; Mohammadi R · Explore (New York, N.Y.) · 2024
    Randomized trial62 participantsMental Focus forBacopa
  30. Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes.
    Neale C; Camfield D; Reay J; Stough C; Scholey A · British journal of clinical pharmacology · 2013
    Systematic reviewMental Focus forBacopa
  31. Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review.
    Al Shahab S; Al Balushi R; Qambar A; Abdulla R; Qader M; Abdulla S; Jahrami H · Nutrients · 2025
    Systematic reviewMental Focus forBacopa
  32. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  33. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  34. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  35. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  36. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  37. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.
    Calabrese C; Gregory WL; Leo M; Kraemer D; Bone K; Oken B · Journal of alternative and complementary medicine (New York, N.Y.) · 2009
    Randomized trial54 participantsProductivity Boost forBacopa
  38. Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial.
    Stough C; Downey LA; Lloyd J; Silber B; Redman S; Hutchison C; Wesnes K; Nathan PJ · Phytotherapy research : PTR · 2009
    Randomized trial107 participantsProductivity Boost forBacopa
  39. An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance.
    Downey LA; Kean J; Nemeh F; Lau A; Poll A; Gregory R; Murray M; Rourke J; Patak B; Pase MP; Zangara A; Lomas J; Scholey A; Stough C · Phytotherapy research : PTR · 2014
    Randomized trial24 participantsProductivity Boost forBacopa
  40. Acute Cordyceps militaris supplementation and elevated resting oxygen uptake with faster reaction times: A randomized crossover trial
    Hamidreza Farzan, Maryam Koushkie Jahromi · PLOS ONE · 2026
    Randomized trial12 participantsProductivity Boost forCordyceps
  41. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  42. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  43. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  44. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  45. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo